2025-12-24 - Analysis Report
Here's an analysis of Tempus AI (TEM) based on the provided data:

**1) Return Rate Comparison**

*   **Simple Numbers:**
    *   Tempus AI Cumulative Return: 15.06%
    *   S&P 500 (VOO) Cumulative Return: 30.11%
    *   Divergence: -15.0 (Relative Divergence: 22.3)

*   **Simple Analysis:**
    *   Tempus AI Inc: A technology company focused on precision medicine through data and artificial intelligence.
    *   Tempus AI has significantly underperformed the S&P 500. The divergence of -15% indicates that Tempus AI's returns have lagged behind the broader market. The relative divergence of 22.3 suggests that the current divergence is closer to the minimum end of the past fluctuation range.
    *   The Alpha, Beta analysis indicates that Tempus AI has a positive CAGR of 15.0% but is more volatile, indicated by 76.7% MDD, and is a risky investment, indicated by -14.0% Alpha.

**2) Recent Stock Price Fluctuations**

*   **Simple Numbers:**
    *   Current Close: $64.46
    *   Last Market Price: $64.72, Previous Close: $65.92, Change: -$1.82
    *   5-day SMA: $65.61
    *   20-day SMA: $72.86
    *   60-day SMA: $80.13

*   **Simple Analysis:**
    *   The stock price is declining, as evidenced by the negative change in the last market price and the fact that the current price is below all three moving averages. The 5-day SMA is below the 20-day SMA, which is below the 60-day SMA, confirming a downward trend.

**3) Technical Indicators**

*   **Simple Numbers:**
    *   Market Risk Indicator (MRI): 0.8 (Medium Investment)
    *   RSI: 23.89
    *   PPO: -1.42
    *   Recent Relative Divergence Change (20 days): -9.7 (Negative trend)
    *   Hybrid Signal: cash_0%_Buy 100% of cash (14 shares - Very Safe - MRI:0.90) Monthly invest 5.0% of total investment ($1,000.00)
    *   Expected Return: Not Available

*   **Simple Analysis:**
    *   The Market Risk Indicator suggests a medium level of investment risk.
    *   The RSI of 23.89 indicates the stock is oversold and may be due for a rebound.
    *   The negative PPO suggests a bearish trend.
    *   The negative change in relative divergence confirms a short-term downward trend.
    *   **The hybrid signal is recommending to buy stock.**

**4) Recent News & Significant Events**

*   **Key Headlines and Their Implications:**

    *   **FDA Clearance Opinions/Price Drop:** Indicates possible mixed sentiment regarding regulatory approvals and market reaction.
    *   **Insider Selling (CEO):** Can be a negative signal, as it suggests the CEO may believe the stock is overvalued or has better uses for the capital.
    *   **Price Target Reductions (BofA, JPMorgan):** Negative, reflects concerns about valuation.
    *   **Approaching Profitability Despite GAAP Losses:** Positive, suggests the company is improving its financial performance.
    *   **"Next Big AI Stock":** Positive, bullish outlook.
    *   **Technical Benchmark:** indicates the stock is trying to meet expectations but has not yet met them.

**4-2) Analyst Opinions:**

*   **Simple Numbers:**
    *   Consensus: Buy (~2.14)
    *   Opinions: 12
    *   Target Price: Average: $88.92, High: $105.00, Low: $80.00

*   **Simple Analysis:**
    *   Analysts generally have a "Buy" rating on the stock, with a significant upside potential based on the average target price.
    *   However, the recent price target reductions by BofA and JPMorgan contradict this positive outlook.

**5) Comprehensive Analysis**

Tempus AI (TEM) presents a mixed picture. While the company operates in a high-growth sector (AI in medicine) and analysts maintain a "Buy" rating with a significant upside target, the stock has significantly underperformed the broader market and is currently in a downward trend.

**Negative Factors:**

*   **Underperformance:** Significant underperformance compared to the S&P 500.
*   **Downward Trend:** Stock price is below key moving averages.
*   **Recent Price Target Reductions:** Negative sentiment from major financial institutions.
*   **Insider Selling:** CEO selling shares raises concerns.
*   **Expected Return:** Not Available, raises concerns about the future viability of the stock.

**Positive Factors:**

*   **Analyst Ratings:** General "Buy" consensus and high target prices.
*   **Approaching Profitability:** Potential for improved financial performance.
*   **Oversold Condition:** RSI suggests a potential rebound.
*   **Hybrid Signal:** Recommending to buy stocks.
*   **"Next Big AI Stock":** May be a buying opportunity.

**Overall, investing in Tempus AI appears to be a high-risk, high-reward proposition.** The company shows strong growth potential but is also surrounded by concerns. The positive analyst consensus and potential rebound opportunities need to be weighed against the recent price declines, negative news sentiment, and insider selling. **Investors should conduct thorough due diligence and consider their risk tolerance before investing.**


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.